ArticleFrontiers in public health2022

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study.

Hong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.